Michal Swierniak
Overview
Explore the profile of Michal Swierniak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Furmanczyk-Zawiska A, Kubiak-Dydo A, Uzarowska-Gaska E, Kotlarek-Lysakowska M, Salata K, Kolanowska M, et al.
J Pers Med
. 2021 Apr;
11(4).
PMID: 33920896
Atypical hemolytic uremic syndrome (aHUS) is a rare disease triggered by dysregulation of the alternative complement pathway, consisting of a characteristic triad of nonimmune hemolytic anemia, thrombocytopenia, and renal failure....
2.
Bednarek M, Trybus M, Kolanowska M, Koziej M, Kiec-Wilk B, Dobosz A, et al.
Mol Genet Genomic Med
. 2021 Jan;
9(3):e1594.
PMID: 33486847
Background: Brachydactylies are a group of inherited conditions, characterized mainly by the presence of shortened fingers and toes. Based on the patients' phenotypes, brachydactylies have been subdivided into 10 subtypes....
3.
Oczko-Wojciechowska M, Pfeifer A, Jarzab M, Swierniak M, Rusinek D, Tyszkiewicz T, et al.
Pathobiology
. 2020 Apr;
87(2):143-154.
PMID: 32320975
Transcriptome of papillary thyroid cancer (PTC) is well characterized and correlates with some prognostic and genotypic factors, but data addressing the interaction between PTC and tumor microenvironment (TME) are scarce....
4.
Papaioannou D, Volinia S, Nicolet D, Swierniak M, Petri A, Mrozek K, et al.
Blood Adv
. 2020 Jan;
4(2):239-251.
PMID: 31945158
Circular RNAs (circRNAs) are noncoding RNA molecules that display a perturbed arrangement of exons, called backsplicing. To examine the prognostic and biologic significance of circRNA expression in cytogenetically normal acute...
5.
Kotlarek M, Kubiak A, Czetwertynska M, Swierniak M, Gierlikowski W, Kolanowska M, et al.
Int J Mol Sci
. 2018 Mar;
19(3).
PMID: 29495389
Aberrant expression of the sodium-iodide symporter (NIS) and the resistance to post-operative radioactive iodide treatment is a crucial cause of higher mortality of some thyroid cancer patients. In this study,...
6.
Kurylowicz A, Wicik Z, Owczarz M, Jonas M, Kotlarek M, Swierniak M, et al.
Int J Mol Sci
. 2017 Dec;
19(1).
PMID: 29280944
Both obesity and weight loss may cause molecular changes in adipose tissue. This study aimed to characterize changes in adipose tissue miRNome in order to identify molecular pathways affected by...
7.
Kolanowska M, Wojcicka A, Kubiak A, Swierniak M, Kotlarek M, Maciag M, et al.
Sci Rep
. 2017 Sep;
7(1):9942.
PMID: 28855631
MicroRNAs, non-coding regulators of gene expression, are known culprits of thyroid cancer. Using next-generation sequencing, we identified a novel microRNA gene, encoded within an important thyroid regulator - thyroglobulin, and...
8.
Kula D, Kalemba M, Puch Z, Polanska J, Swierniak M, Rusinek D, et al.
Endokrynol Pol
. 2017 Jun;
68(3):283-289.
PMID: 28660995
Introduction: Papillary thyroid cancer (PTC) shows familial occurrence, and some susceptibility single nucleotide polymorphisms (SNPs) have been identified in FOXE1 and near the NKX2-1 locus. The aim of our study...
9.
Wojtas B, Pfeifer A, Oczko-Wojciechowska M, Krajewska J, Czarniecka A, Kukulska A, et al.
Int J Mol Sci
. 2017 Jun;
18(6).
PMID: 28574441
Distinguishing between follicular thyroid cancer (FTC) and follicular thyroid adenoma (FTA) constitutes a long-standing diagnostic problem resulting in equivocal histopathological diagnoses. There is therefore a need for additional molecular markers....
10.
Przybyl J, Kowalewska M, Quattrone A, Dewaele B, Vanspauwen V, Varma S, et al.
JCI Insight
. 2017 Jun;
2(11).
PMID: 28570276
Endometrial stromal tumors include translocation-associated low- and high-grade endometrial stromal sarcomas (ESS) and highly malignant undifferentiated uterine sarcomas (UUS). UUS is considered a poorly defined group of aggressive tumors and...